From Donor to Development: Minimizing Risks in the Cell Starting Materials Supply Chain
25 Sep 2024
Monterey
Cell Therapy Development
)
- Identify the key risks that impact supply chain and manufacturing processes.
- The essential components of a robust regulatory and manufacturing framework.
- Identify key attributes for HCT/Ps and ancillary source material providers.
Industry Expert
